| 1 |
35058324 | Vectorized Treg-depleting αCTLA-4 elicits antigen cross-presentation and CD8+ T cell immunity to reject 'cold' tumors. | 2022 Jan |
1 |
| 2 |
33588426 | CTLA-4 blockade drives loss of Treg stability in glycolysis-low tumours. | 2021 Mar |
2 |
| 3 |
34588224 | Leveraging the Treg-intrinsic CTLA4-PKCη signaling pathway for cancer immunotherapy. | 2021 Sep |
1 |
| 4 |
31554638 | A Neuropilin-1 Antagonist Exerts Antitumor Immunity by Inhibiting the Suppressive Function of Intratumoral Regulatory T Cells. | 2020 Jan |
1 |
| 5 |
32948683 | Foxp3+ Regulatory T Cell Depletion after Nonablative Oligofractionated Irradiation Boosts the Abscopal Effects in Murine Malignant Mesothelioma. | 2020 Nov 1 |
1 |
| 6 |
33384695 | Beyond T-Cells: Functional Characterization of CTLA-4 Expression in Immune and Non-Immune Cell Types. | 2020 |
1 |
| 7 |
31076558 | TLR1/2 ligand enhances antitumor efficacy of CTLA-4 blockade by increasing intratumoral Treg depletion. | 2019 May 21 |
1 |
| 8 |
29472691 | A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy. | 2018 Apr |
1 |
| 9 |
30687329 | Ethyl Pyruvate Stimulates Regulatory T Cells and Ameliorates Type 1 Diabetes Development in Mice. | 2018 |
1 |
| 10 |
24218453 | Antigen-specific induced T regulatory cells impair dendritic cell function via an IL-10/MARCH1-dependent mechanism. | 2013 Dec 15 |
1 |
| 11 |
22759373 | CTLA4-Ig restores rejection of MHC class-II mismatched allografts by disabling IL-2-expanded regulatory T cells. | 2012 Sep |
1 |
| 12 |
19811462 | PD-1 but not CTLA-4 blockage abrogates the protective effect of regulatory T cells in a pregnancy murine model. | 2009 Nov |
2 |
| 13 |
16886063 | Inhibition of T cell activation and autoimmune diabetes using a B cell surface-linked CTLA-4 agonist. | 2006 Aug |
1 |
| 14 |
15468055 | Distinct roles of CTLA-4 and TGF-beta in CD4+CD25+ regulatory T cell function. | 2004 Nov |
2 |